Cargando…

Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study

Quickly-pulse-to-pulse (Q-PTP) is the latest dual pulse mode Q-switched neodymium-doped yttrium aluminum garnet [QS Nd:YAG (QSNY)] laser technology that improves efficacy and minimizes side effects. In this study, the safety, efficacy, and advantages of Q-PTP and single-pulse laser mode of 1064-nm Q...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiaorui, Cai, Xiaojian, Jin, Yudan, Zhang, Taohua, Wang, Bulin, Li, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733004/
https://www.ncbi.nlm.nih.gov/pubmed/31516612
http://dx.doi.org/10.3892/ol.2019.10743
_version_ 1783449906477793280
author Guo, Xiaorui
Cai, Xiaojian
Jin, Yudan
Zhang, Taohua
Wang, Bulin
Li, Qin
author_facet Guo, Xiaorui
Cai, Xiaojian
Jin, Yudan
Zhang, Taohua
Wang, Bulin
Li, Qin
author_sort Guo, Xiaorui
collection PubMed
description Quickly-pulse-to-pulse (Q-PTP) is the latest dual pulse mode Q-switched neodymium-doped yttrium aluminum garnet [QS Nd:YAG (QSNY)] laser technology that improves efficacy and minimizes side effects. In this study, the safety, efficacy, and advantages of Q-PTP and single-pulse laser mode of 1064-nm QSNY in the treatment of melasma were compared. Twelve healthy women were enrolled in this split-face study. Q-PTP and single-pulse laser mode of 1064-nm QSNY were applied to the treatment side and the control side, respectively. Physician's global assessment, patients' self-assessment and the modified melasma area and severity index (mMASI) scores were used to quantify pigmentation changes. Side effects were recorded. Mean mMASI scores were decreased significantly at the 4th and 12th-week follow-up visit compared to the baseline. Melasma lesion clearance was more than 50% in 58% of patients compared with the baseline. However, both sides of the same patient showed similar therapeutic effect. Minor pain experience and slighter skin erythema reaction were reported in Q-PTP laser mode treatment side compared with the control. No serious complications were found in any of the patients. Q-PTP laser mode of 1064-nm QSNY is an optimal laser therapy in the treatment of melasma with greater safety and superiority.
format Online
Article
Text
id pubmed-6733004
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-67330042019-09-12 Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study Guo, Xiaorui Cai, Xiaojian Jin, Yudan Zhang, Taohua Wang, Bulin Li, Qin Oncol Lett Articles Quickly-pulse-to-pulse (Q-PTP) is the latest dual pulse mode Q-switched neodymium-doped yttrium aluminum garnet [QS Nd:YAG (QSNY)] laser technology that improves efficacy and minimizes side effects. In this study, the safety, efficacy, and advantages of Q-PTP and single-pulse laser mode of 1064-nm QSNY in the treatment of melasma were compared. Twelve healthy women were enrolled in this split-face study. Q-PTP and single-pulse laser mode of 1064-nm QSNY were applied to the treatment side and the control side, respectively. Physician's global assessment, patients' self-assessment and the modified melasma area and severity index (mMASI) scores were used to quantify pigmentation changes. Side effects were recorded. Mean mMASI scores were decreased significantly at the 4th and 12th-week follow-up visit compared to the baseline. Melasma lesion clearance was more than 50% in 58% of patients compared with the baseline. However, both sides of the same patient showed similar therapeutic effect. Minor pain experience and slighter skin erythema reaction were reported in Q-PTP laser mode treatment side compared with the control. No serious complications were found in any of the patients. Q-PTP laser mode of 1064-nm QSNY is an optimal laser therapy in the treatment of melasma with greater safety and superiority. D.A. Spandidos 2019-10 2019-08-14 /pmc/articles/PMC6733004/ /pubmed/31516612 http://dx.doi.org/10.3892/ol.2019.10743 Text en Copyright: © Guo et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Guo, Xiaorui
Cai, Xiaojian
Jin, Yudan
Zhang, Taohua
Wang, Bulin
Li, Qin
Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study
title Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study
title_full Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study
title_fullStr Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study
title_full_unstemmed Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study
title_short Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study
title_sort q-ptp is an optimized technology of 1064-nm q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: a prospective split-face study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733004/
https://www.ncbi.nlm.nih.gov/pubmed/31516612
http://dx.doi.org/10.3892/ol.2019.10743
work_keys_str_mv AT guoxiaorui qptpisanoptimizedtechnologyof1064nmqswitchedneodymiumdopedyttriumaluminumgarnetlaserinthelasertherapyofmelasmaaprospectivesplitfacestudy
AT caixiaojian qptpisanoptimizedtechnologyof1064nmqswitchedneodymiumdopedyttriumaluminumgarnetlaserinthelasertherapyofmelasmaaprospectivesplitfacestudy
AT jinyudan qptpisanoptimizedtechnologyof1064nmqswitchedneodymiumdopedyttriumaluminumgarnetlaserinthelasertherapyofmelasmaaprospectivesplitfacestudy
AT zhangtaohua qptpisanoptimizedtechnologyof1064nmqswitchedneodymiumdopedyttriumaluminumgarnetlaserinthelasertherapyofmelasmaaprospectivesplitfacestudy
AT wangbulin qptpisanoptimizedtechnologyof1064nmqswitchedneodymiumdopedyttriumaluminumgarnetlaserinthelasertherapyofmelasmaaprospectivesplitfacestudy
AT liqin qptpisanoptimizedtechnologyof1064nmqswitchedneodymiumdopedyttriumaluminumgarnetlaserinthelasertherapyofmelasmaaprospectivesplitfacestudy